 |
InterPro: IPR013128 Peptidase C1A, papain
Protein matches
|
UniProtKB Matches: 4219 proteins |
|
Accession
|
IPR013128 Peptidase_C1A |
Secondary
|
IPR000668
|
Type
|
Family |
Signatures
|
|
InterPro Relationships
|
|
Children
|
IPR015643 Peptidase C1A, cathepsin B
IPR015644 Peptidase C1A, cathepsin K
IPR015645 Peptidase C1A, placentally-expressed cathepsin
|
|
Contains
|
IPR000169 Peptidase, cysteine peptidase active site
IPR000668 Peptidase C1A, papain C-terminal
IPR012599 Peptidase C1A, propeptide
IPR013201 Proteinase inhibitor I29, cathepsin propeptide
|
GO Term annotation
|
|
Function
|
GO:0008234 cysteine-type peptidase activity
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
In the MEROPS database peptidases and peptidase homologues are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry based on a common structural fold:
- Each clan is identified with two letters, the first representing the catalytic type of the families included in the clan (with the letter 'P' being used for a clan containing families of more than one of the catalytic types serine, threonine and cysteine). Some families cannot yet be assigned to clans, and when a formal assignment is required, such a family is described as belonging to clan A-, C-, M-, S-, T- or U-, according to the catalytic type. Some clans are divided into subclans because there is evidence of a very ancient divergence within the clan, for example MA(E), the gluzincins, and MA(M), the metzincins.
- Peptidase families are grouped by their catalytic type, the first character representing the catalytic type: A, aspartic; C, cysteine; G, glutamic acid; M, metallo; S, serine; T, threonine; and U, unknown. The serine, threonine and cysteine peptidases utilise the amino acid as a nucleophile and form an acyl intermediate - these peptidases can also readily act as transferases. In the case of aspartic, glutamic and metallopeptidases, the nucleophile is an activated water molecule.
In many instances the structural protein fold that characterises the clan or family may have lost its catalytic activity, yet retain its function in protein recognition and binding.
Cysteine peptidases have characteristic molecular topologies, which can be seen not only in their three-dimensional structures, but commonly also in the two-dimensional structures. These are peptidases in which the nucleophile is the sulphydryl group of a cysteine residue. Cysteine proteases are divided into clans (proteins which are evolutionary related), and further sub-divided into families, on the basis of the architecture of their catalytic dyad or triad [1].
This group of cysteine peptidases belong to MEROPS peptidase family C1, sub-family C1A (papain family, clan CA). It includes proteins classed as non-peptidase homologs. These are have either been shown experimentally to lack peptidase activity or lack one or more of the active site residues.
The papain family has a wide variety of activities, including broad-range (papain) and narrow-range endo-peptidases, aminopeptidases, dipeptidyl peptidases and enzymes with both exo- and endo-peptidase activity [2]. Members of the papain family are widespread, found in baculovirus [3], eubacteria, yeast, and practically all protozoa, plants and mammals [2]. The proteins are typically
lysosomal or secreted, and proteolytic cleavage of the propeptide is required for enzyme activation, although bleomycin hydrolase is cytosolic in fungi and mammals [4]. Papain-like cysteine proteinases are essentially synthesised as inactive proenzymes (zymogens) with N-terminal propeptide regions. The activation process of these enzymes includes the removal of propeptide regions. The propeptide regions serve a variety of functions in vivo and in vitro. The pro-region is required for the proper folding of the newly synthesised enzyme, the inactivation of the peptidase domain and stabilisation of the enzyme against denaturing at neutral to alkaline pH conditions. Amino acid residues within the pro-region mediate their membrane association, and play a role in the transport of the proenzyme to lysosomes. Among the most notable features of propeptides is their ability to inhibit the activity of their cognate enzymes and that certain propeptides exhibit high selectivity for inhibition of the peptidases from which they originate [5].
The catalytic residues of papain are Cys-25 and His-159, other important residues being Gln-19, which helps form the 'oxyanion hole', and Asn-175, which orientates the imidazole ring of His-159.
|
Structural links
|
|
Database links
|
|
Publications
|
|
1.
|
Barrett AJ, Rawlings ND.
Evolutionary lines of cysteine peptidases.
Biol. Chem. 382 727-33 2001
[PubMed: 11517925]
http://dx.doi.org/10.1515/BC.2001.088
|
|
2.
|
Rawlings ND, Barrett AJ.
Families of cysteine peptidases.
Meth. Enzymol. 244 461-86 1994
[PubMed: 7845226]
http://dx.doi.org/10.1016/0076-6879(94)44034-4
|
|
3.
|
Rawlings ND, Barrett AJ.
Evolutionary families of peptidases.
Biochem. J. 290 ( Pt 1) 205-18 1993
[PubMed: 8439290]
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=8439290&action=stream&blobtype=pdf
|
|
4.
|
Sebti SM, DeLeon JC, Lazo JS.
Purification, characterization, and amino acid composition of rabbit pulmonary bleomycin hydrolase.
Biochemistry 26 4213-9 1987
[PubMed: 3117099]
http://dx.doi.org/10.1021/bi00388a006
|
|
5.
|
Yamamoto Y, Kurata M, Watabe S, Murakami R, Takahashi SY.
Novel cysteine proteinase inhibitors homologous to the proregions of cysteine proteinases.
Curr. Protein Pept. Sci. 3 231-8 2002
[PubMed: 12188906]
http://openurl.ingenta.com/content?genre=article&issn=1389-2037&volume=3&issue=2&spage=231
|
Additional Reading
|
|
Weidauer E, Yasuda Y, Biswal BK, Cherny M, James MN, Bromme D.
Effects of disease-modifying anti-rheumatic drugs (DMARDs) on the activities of rheumatoid arthritis-associated cathepsins K and S.
Biol. Chem. 388 2007 331-6
[PubMed: 17338641]
http://dx.doi.org/10.1515/BC.2007.037
|
|
Li Z, Kienetz M, Cherney MM, James MN, Bromme D.
The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex.
J. Mol. Biol. 383 2008 78-91
[PubMed: 18692071]
http://dx.doi.org/10.1016/j.jmb.2008.07.038
|
|
Teno N, Miyake T, Ehara T, Irie O, Sakaki J, Ohmori O, Gunji H, Matsuura N, Masuya K, Hitomi Y, Nonomura K, Horiuchi M, Gohda K, Iwasaki A, Umemura I, Tada S, Kometani M, Iwasaki G, Cowan-Jacob SW, Missbach M, Lattmann R, Betschart C.
Novel scaffold for cathepsin K inhibitors.
Bioorg. Med. Chem. Lett. 17 2007 6096-100
[PubMed: 17911019]
http://dx.doi.org/10.1016/j.bmcl.2007.09.047
|
|
Molgaard A, Arnau J, Lauritzen C, Larsen S, Petersen G, Pedersen J.
The crystal structure of human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2.
Biochem. J. 401 2007 645-50
[PubMed: 17020538]
http://dx.doi.org/10.1042/BJ20061389
|
|
Stack CM, Caffrey CR, Donnelly SM, Seshaadri A, Lowther J, Tort JF, Collins PR, Robinson MW, Xu W, McKerrow JH, Craik CS, Geiger SR, Marion R, Brinen LS, Dalton JP.
Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica.
J. Biol. Chem. 283 2008 9896-908
[PubMed: 18160404]
http://dx.doi.org/10.1074/jbc.M708521200
|
|